Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI19BZ
|
|||
| Drug Name |
KN-002
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Severe asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 1 | [1] | |
| Company |
Kinaset Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05006521) Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, PK, and PD of Single Ascending Doses of KN-002 in Healthy Subjects and Multiple Ascending Doses of KN-002 in Subjects With Mild Asthma, Moderate-Severe Asthma and COPD. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Kinaset Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.